217 related articles for article (PubMed ID: 12093521)
1. LC determination of rosiglitazone in bulk and pharmaceutical formulation.
Radhakrishna T; Satyanarayana J; Satyanarayana A
J Pharm Biomed Anal; 2002 Jul; 29(5):873-80. PubMed ID: 12093521
[TBL] [Abstract][Full Text] [Related]
2. Column high-performance liquid chromatographic method for the simultaneous determination of rosiglitazone and metformin in a pharmaceutical preparation.
Ali AR; Duraidi II; Saket MM; Abu-Nameh ES
J AOAC Int; 2009; 92(1):119-24. PubMed ID: 19382568
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous high-performance liquid chromatographic determination of pioglitazone and metformin in pharmaceutical-dosage form.
Kolte BL; Raut BB; Deo AA; Bagool MA; Shinde DB
J Chromatogr Sci; 2004 Jan; 42(1):27-31. PubMed ID: 14965412
[TBL] [Abstract][Full Text] [Related]
4. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS
J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357
[TBL] [Abstract][Full Text] [Related]
5. Determination of pioglitazone hydrochloride in bulk and pharmaceutical formulations by HPLC and MEKC methods.
Radhakrishna T; Sreenivas Rao D; Om Reddy G
J Pharm Biomed Anal; 2002 Jul; 29(4):593-607. PubMed ID: 12093488
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods.
Radhakrishna T; Narasaraju A; Ramakrishna M; Satyanarayana A
J Pharm Biomed Anal; 2003 Feb; 31(2):359-68. PubMed ID: 12609675
[TBL] [Abstract][Full Text] [Related]
7. LC determination of glimepiride and its related impurities.
Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
[TBL] [Abstract][Full Text] [Related]
8. A novel validated LC method for quantitation of lopinavir in bulk drug and pharmaceutical formulation in the presence of its potential impurities and degradation products.
Seshachalam U; Haribabu B; Chandrasekhar K
Biomed Chromatogr; 2007 Jul; 21(7):716-23. PubMed ID: 17370253
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of metformin in combination with rosiglitazone by reversed-phase liquid chromatography.
Kolte BL; Raut BB; Deo AA; Bagool MA; Shinde DB
J Chromatogr Sci; 2004 Feb; 42(2):70-3. PubMed ID: 15023258
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method.
A K; G S; C MR; Bhat K; A R; P M; M S; K K; N U
Pak J Pharm Sci; 2008 Oct; 21(4):421-5. PubMed ID: 18930865
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatographic method for the determination of rosiglitazone in human plasma.
Kolte BL; Raut BB; Deo AA; Bagool MA; Shinde DB
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):37-44. PubMed ID: 12668069
[TBL] [Abstract][Full Text] [Related]
12. Method development and validation for the HPLC potency assay of troglitazone tablets.
Lambropoulos J; Bergholdt AB
J Pharm Biomed Anal; 2000 Dec; 24(2):251-8. PubMed ID: 11130204
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.
den Brok MW; Nuijen B; Hillebrand MJ; Grieshaber CK; Harvey MD; Beijnen JH
J Pharm Biomed Anal; 2005 Sep; 39(1-2):46-53. PubMed ID: 15899571
[TBL] [Abstract][Full Text] [Related]
14. Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standard.
Mamidi RN; Benjamin B; Ramesh M; Srinivas NR
Biomed Chromatogr; 2003 Sep; 17(6):417-20. PubMed ID: 13680854
[TBL] [Abstract][Full Text] [Related]
15. Validated high performance liquid chromatographic method for simultaneous determination of rosiglitazone, cilostazol, and 3,4-dehydro-cilostazol in rat plasma and its application to pharmacokinetics.
Varanasi VS; Veeraraghavan S; Potharaju S; Thappali RS; Raghavan R; Vakkalanka VS
Arzneimittelforschung; 2008; 58(6):288-96. PubMed ID: 18677971
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
[TBL] [Abstract][Full Text] [Related]
17. Determination of tropicamide in pharmaceutical formulations using high-performance liquid chromatography.
Amanlou M; Asmardi G; Andalibi PC; Javadi N; Khodadady F; Omarny ZB
J Chromatogr A; 2005 Sep; 1088(1-2):136-9. PubMed ID: 16130742
[TBL] [Abstract][Full Text] [Related]
18. Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products.
Chaudhari BG; Patel NM; Shah PB; Patel LJ; Patel VP
J AOAC Int; 2007; 90(6):1539-46. PubMed ID: 18193730
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals.
Nageswara Rao R; Nagaraju D; Alvi SN; Bhirud SB
J Pharm Biomed Anal; 2004 Nov; 36(4):759-67. PubMed ID: 15533668
[TBL] [Abstract][Full Text] [Related]
20. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z
J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
